Related Experiment Video
Updated: Sep 30, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Lack of correlation between left ventricular mass and diameter of left coronary artery main trunk in hypertensive
C Cuspidi1, L Lonati, L Sampieri
1Istituto di Clinica Medica Generale e Terapia Medica and Centro Fisiologia Clinica e Ipertensione, Università di Milano and Ospedale Maggiore, IRCCS, Milano, Italy.
Insights
In essential hypertension, increased left ventricular mass does not correlate with left coronary artery diameter. This suggests a potential mechanism for impaired coronary blood flow in hypertensive heart disease.
Area of Science:
- Cardiology
- Hypertension Research
- Vascular Biology
Background:
- Essential hypertension is linked to left ventricular hypertrophy (LVH).
- The relationship between increased left ventricular mass and coronary artery dimensions in hypertension requires clarification.
Purpose of the Study:
- To investigate if increased left ventricular mass in essential hypertensives is proportionally associated with left coronary artery (LCA) trunk diameter.
- To explore potential mechanisms for coronary blood flow impairment in hypertensive patients with LVH.
Main Methods:
- Echocardiography was used to measure left ventricular (LV) dimensions and calculate LV mass index (LVMI).
- Left coronary artery (LCA) trunk diameter was measured using 2D echocardiography.
- Study included 26 hypertensives (14 with LVH, 12 without) and 10 normotensive controls.
Main Results:
- LVMI was significantly higher in hypertensives with LVH compared to those without and controls.
- LCA trunk diameter was similar across all groups (hypertensives with LVH, hypertensives without LVH, and controls).
- No significant correlation was found between LVMI and LCA diameter in hypertensive patients.
Conclusions:
- Increased left ventricular mass in essential hypertension is not accompanied by a proportional increase in epicardial LCA diameter.
- This disproportion may contribute to the reduced coronary blood flow reserve observed in patients with LVH.
Abstract:
The study was designed to evaluate whether the increase in left ventricular (LV) mass in essential hypertensives (H) is associated with a proportional increase in diameter of the left coronary artery (LCA) trunk. Twenty-six hypertensives, 14 with left ventricular hypertrophy (LVH) (left ventricular mass index [LVMI] > or =134 g/m2 in men and > or =110 g/m2 in women) and 12 without LVH, and 10 normotensive controls (C) underwent clinical laboratory and echocardiographic transthoracic examination. LV dimensions were measured according to the Penn convention and LV mass calculated by the formula of Devereux. The LCA main trunk was visualized by two-dimension short axis view at the level of the great vessels section, and the diameter measured as intima-intima distance at end-diastole. Hypertensives with and without LVH and C had similar age, sex, and body surface area distribution. LVMI was, by definition, significantly higher in H with LVH than in H without LVH and in C (144+/-21, 113+/-13, and 98+/-10 g/m2, P<.01), whereas the diameter of the LCA trunk was similar in all groups (0.48+/-0.1, 0.48, and 0.46 cm, respectively). There was no significant correlation between LVMI and LCA diameter in H (r = 0.21, P = not significant). The diameter of LCA trunk was significantly correlated only with BSA (r = 0.5, P<.01), LV end-systolic and end-diastolic diameters (r = 0.5 and r = 0.4, P<.05). Our data suggest that in H the increase in LVM is not associated with a concomitant increase of epicardial coronary artery diameter, and this finding may account in part for the impairment of coronary blood flow reserve in LVH.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

